0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Paclitaxel Injection Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-27P15730
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Paclitaxel Injection Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Paclitaxel Injection Market Report & Forecast 2023-2029

Code: QYRE-Auto-27P15730
Report
November 2023
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Paclitaxel Injection Market Size

The global Paclitaxel Injection revenue was US$ 3384 million in 2022 and is forecast to a readjusted size of US$ 7130.2 million by 2029 with a CAGR of 11.1% during the forecast period (2023-2029).

and India Paclitaxel Injection Market

and India Paclitaxel Injection Market

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
In India, the Paclitaxel Injection revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.
In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.
This report focuses on global and India Paclitaxel Injection market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Paclitaxel Injection will continue to grow rapidly in the future.
Global Paclitaxel Injection Scope and Market Size
Paclitaxel Injection market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Paclitaxel Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Paclitaxel Injection market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Paclitaxel Injection Market Report

Report Metric Details
Report Name and India Paclitaxel Injection Market
Forecasted market size in 2029 US$ 7130.2 million
CAGR 11.1%
Forecasted years 2023 - 2029
Segment by Type
  • 5ml,30mg
  • 10ml,60mg
  • 16.7ml,100mg
  • 25ml,150mg
  • 50ml,300mg
Segment by Application
  • Ovarian Cancer
  • Breast Cancer
  • Cervical Cancer
  • Pancreatic Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Paclitaxel Injection Market size in 2029?

Ans: The and India Paclitaxel Injection Market size in 2029 will be US$ 7130.2 million.

What is the market share of major companies in and India Paclitaxel Injection Market?

Ans: Global top five players hold a share about 80%.

What is the and India Paclitaxel Injection Market share by type?

Ans: In terms of product, 5ml,30mg is the largest segment, with a share about 75%.

What is the and India Paclitaxel Injection Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Paclitaxel Injection Market report?

Ans: The main players in the and India Paclitaxel Injection Market are Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch

What are the Application segmentation covered in the and India Paclitaxel Injection Market report?

Ans: The Applications covered in the and India Paclitaxel Injection Market report are Ovarian Cancer, Breast Cancer, Cervical Cancer, Pancreatic Cancer, Other

What are the Type segmentation covered in the and India Paclitaxel Injection Market report?

Ans: The Types covered in the and India Paclitaxel Injection Market report are 5ml,30mg, 10ml,60mg, 16.7ml,100mg, 25ml,150mg, 50ml,300mg

1 Study Coverage
1.1 Paclitaxel Injection Product Introduction
1.2 Global Paclitaxel Injection Outlook 2018 VS 2022 VS 2029
1.2.1 Global Paclitaxel Injection Sales in US$ Million for the Year 2018-2029
1.2.2 Global Paclitaxel Injection Sales in Volume for the Year 2018-2029
1.3 India Paclitaxel Injection Outlook 2018 VS 2022 VS 2029
1.3.1 India Paclitaxel Injection Sales in US$ Million for the Year 2018-2029
1.3.2 India Paclitaxel Injection Sales in Volume for the Year 2018-2029
1.4 Paclitaxel Injection Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Paclitaxel Injection in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Paclitaxel Injection Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Paclitaxel Injection Market Dynamics
1.5.1 Paclitaxel Injection Industry Trends
1.5.2 Paclitaxel Injection Market Drivers
1.5.3 Paclitaxel Injection Market Challenges
1.5.4 Paclitaxel Injection Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Paclitaxel Injection by Type
2.1 Paclitaxel Injection Market Segment by Type
2.1.1 5ml,30mg
2.1.2 10ml,60mg
2.1.3 16.7ml,100mg
2.1.4 25ml,150mg
2.1.5 50ml,300mg
2.2 Global Paclitaxel Injection Market Size by Type
2.2.1 Global Paclitaxel Injection Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Paclitaxel Injection Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Paclitaxel Injection Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Paclitaxel Injection Market Size by Type
2.3.1 India Paclitaxel Injection Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Paclitaxel Injection Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Paclitaxel Injection Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Paclitaxel Injection by Application
3.1 Paclitaxel Injection Market Segment by Application
3.1.1 Ovarian Cancer
3.1.2 Breast Cancer
3.1.3 Cervical Cancer
3.1.4 Pancreatic Cancer
3.1.5 Other
3.2 Global Paclitaxel Injection Market Size by Application
3.2.1 Global Paclitaxel Injection Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Paclitaxel Injection Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Paclitaxel Injection Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Paclitaxel Injection Market Size by Application
3.3.1 India Paclitaxel Injection Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Paclitaxel Injection Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Paclitaxel Injection Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Paclitaxel Injection Competitor Landscape by Company
4.1 Global Paclitaxel Injection Market Size by Company
4.1.1 Global Key Manufacturers of Paclitaxel Injection, Ranked by Revenue (2022)
4.1.2 Global Paclitaxel Injection Revenue by Manufacturer (2018-2023)
4.1.3 Global Paclitaxel Injection Sales by Manufacturer (2018-2023)
4.1.4 Global Paclitaxel Injection Price by Manufacturer (2018-2023)
4.2 Global Paclitaxel Injection Concentration Ratio (CR)
4.2.1 Paclitaxel Injection Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Paclitaxel Injection in 2022
4.2.3 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Paclitaxel Injection, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Paclitaxel Injection, Product Offered and Application
4.5 Global Key Manufacturers of Paclitaxel Injection, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Paclitaxel Injection Market Size by Company
4.7.1 Key Players of Paclitaxel Injection in India, Ranked by Revenue (2022)
4.7.2 India Paclitaxel Injection Revenue by Players (2018-2023)
4.7.3 India Paclitaxel Injection Sales by Players (2018-2023)
5 Global Paclitaxel Injection Market Size by Region
5.1 Global Paclitaxel Injection Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Paclitaxel Injection Market Size in Volume by Region (2018-2029)
5.2.1 Global Paclitaxel Injection Sales in Volume by Region: 2018-2023
5.2.2 Global Paclitaxel Injection Sales in Volume Forecast by Region (2024-2029)
5.3 Global Paclitaxel Injection Market Size in Value by Region (2018-2029)
5.3.1 Global Paclitaxel Injection Sales in Value by Region: 2018-2023
5.3.2 Global Paclitaxel Injection Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Paclitaxel Injection Market Size YoY Growth 2018-2029
6.2 Americas Paclitaxel Injection Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Paclitaxel Injection Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Paclitaxel Injection Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Paclitaxel Injection Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Paclitaxel Injection Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Paclitaxel Injection Market Size YoY Growth 2018-2029
7.2 EMEA Paclitaxel Injection Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Paclitaxel Injection Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Paclitaxel Injection Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Paclitaxel Injection Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Paclitaxel Injection Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Paclitaxel Injection Market Size YoY Growth 2018-2029
8.2 China Paclitaxel Injection Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Paclitaxel Injection Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Paclitaxel Injection Market Size YoY Growth 2018-2029
9.2 APAC Paclitaxel Injection Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Paclitaxel Injection Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Paclitaxel Injection Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Paclitaxel Injection Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Paclitaxel Injection Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Description and Business Overview
10.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Paclitaxel Injection Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Celgene Corporation
10.2.1 Celgene Corporation Company Information
10.2.2 Celgene Corporation Description and Business Overview
10.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Celgene Corporation Paclitaxel Injection Products Offered
10.2.5 Celgene Corporation Recent Development
10.3 Hospira
10.3.1 Hospira Company Information
10.3.2 Hospira Description and Business Overview
10.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Hospira Paclitaxel Injection Products Offered
10.3.5 Hospira Recent Development
10.4 Biological E.
10.4.1 Biological E. Company Information
10.4.2 Biological E. Description and Business Overview
10.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Biological E. Paclitaxel Injection Products Offered
10.4.5 Biological E. Recent Development
10.5 Taj Accura
10.5.1 Taj Accura Company Information
10.5.2 Taj Accura Description and Business Overview
10.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Taj Accura Paclitaxel Injection Products Offered
10.5.5 Taj Accura Recent Development
10.6 Khandelwal Laboratories
10.6.1 Khandelwal Laboratories Company Information
10.6.2 Khandelwal Laboratories Description and Business Overview
10.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Khandelwal Laboratories Paclitaxel Injection Products Offered
10.6.5 Khandelwal Laboratories Recent Development
10.7 Luye Pharma
10.7.1 Luye Pharma Company Information
10.7.2 Luye Pharma Description and Business Overview
10.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Luye Pharma Paclitaxel Injection Products Offered
10.7.5 Luye Pharma Recent Development
10.8 Beijing Youcare
10.8.1 Beijing Youcare Company Information
10.8.2 Beijing Youcare Description and Business Overview
10.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Beijing Youcare Paclitaxel Injection Products Offered
10.8.5 Beijing Youcare Recent Development
10.9 Beijing Union
10.9.1 Beijing Union Company Information
10.9.2 Beijing Union Description and Business Overview
10.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Beijing Union Paclitaxel Injection Products Offered
10.9.5 Beijing Union Recent Development
10.10 Haiyao
10.10.1 Haiyao Company Information
10.10.2 Haiyao Description and Business Overview
10.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Haiyao Paclitaxel Injection Products Offered
10.10.5 Haiyao Recent Development
10.11 Chuntch
10.11.1 Chuntch Company Information
10.11.2 Chuntch Description and Business Overview
10.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Chuntch Paclitaxel Injection Products Offered
10.11.5 Chuntch Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Paclitaxel Injection Industry Chain Analysis
11.2 Paclitaxel Injection Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Paclitaxel Injection Production Mode & Process
11.4 Paclitaxel Injection Sales and Marketing
11.4.1 Paclitaxel Injection Sales Channels
11.4.2 Paclitaxel Injection Distributors
11.5 Paclitaxel Injection Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Paclitaxel Injection CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Paclitaxel Injection Market Trends
    Table 3. Paclitaxel Injection Market Drivers
    Table 4. Paclitaxel Injection Market Challenges
    Table 5. Paclitaxel Injection Market Restraints
    Table 6. Global Paclitaxel Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Paclitaxel Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Paclitaxel Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Paclitaxel Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Paclitaxel Injection, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Paclitaxel Injection Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Paclitaxel Injection Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Paclitaxel Injection Sales by Manufacturer, (K Units), 2018-2023
    Table 14. Global Paclitaxel Injection Sales Share by Manufacturer, 2018-2023
    Table 15. Global Paclitaxel Injection Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 16. Global Paclitaxel Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2022)
    Table 18. Global Key Manufacturers of Paclitaxel Injection, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Paclitaxel Injection, Product Offered and Application
    Table 20. Global Key Manufacturers of Paclitaxel Injection, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Paclitaxel Injection in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Paclitaxel Injection Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Paclitaxel Injection Revenue Share by Players, (2018-2023)
    Table 25. India Paclitaxel Injection Sales by Players, (K Units), (2018-2023)
    Table 26. India Paclitaxel Injection Sales Share by Players, (2018-2023)
    Table 27. Global Paclitaxel Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Paclitaxel Injection Sales in Volume by Region (2018-2023) & (K Units)
    Table 29. Global Paclitaxel Injection Sales in Volume Forecast by Region (2024-2029) & (K Units)
    Table 30. Global Paclitaxel Injection Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Paclitaxel Injection Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Paclitaxel Injection Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Paclitaxel Injection Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Paclitaxel Injection Sales in Volume by Country (2018-2023) & (K Units)
    Table 36. Americas Paclitaxel Injection Sales in Volume by Country (2024-2029) & (K Units)
    Table 37. EMEA Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Paclitaxel Injection Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Paclitaxel Injection Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Paclitaxel Injection Sales in Volume by Country (2018-2023) & (K Units)
    Table 41. EMEA Paclitaxel Injection Sales in Volume by Country (2024-2029) & (K Units)
    Table 42. APAC Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Paclitaxel Injection Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Paclitaxel Injection Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Paclitaxel Injection Sales in Volume by Country (2018-2023) & (K Units)
    Table 46. APAC Paclitaxel Injection Sales in Volume by Country (2024-2029) & (K Units)
    Table 47. Bristol-Myers Squibb Company Information
    Table 48. Bristol-Myers Squibb Description and Business Overview
    Table 49. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 50. Bristol-Myers Squibb Paclitaxel Injection Product
    Table 51. Bristol-Myers Squibb Recent Development
    Table 52. Celgene Corporation Company Information
    Table 53. Celgene Corporation Description and Business Overview
    Table 54. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 55. Celgene Corporation Paclitaxel Injection Product
    Table 56. Celgene Corporation Recent Development
    Table 57. Hospira Company Information
    Table 58. Hospira Description and Business Overview
    Table 59. Hospira Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 60. Hospira Paclitaxel Injection Product
    Table 61. Hospira Recent Development
    Table 62. Biological E. Company Information
    Table 63. Biological E. Description and Business Overview
    Table 64. Biological E. Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 65. Biological E. Paclitaxel Injection Product
    Table 66. Biological E. Recent Development
    Table 67. Taj Accura Company Information
    Table 68. Taj Accura Description and Business Overview
    Table 69. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 70. Taj Accura Paclitaxel Injection Product
    Table 71. Taj Accura Recent Development
    Table 72. Khandelwal Laboratories Company Information
    Table 73. Khandelwal Laboratories Description and Business Overview
    Table 74. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 75. Khandelwal Laboratories Paclitaxel Injection Product
    Table 76. Khandelwal Laboratories Recent Development
    Table 77. Luye Pharma Company Information
    Table 78. Luye Pharma Description and Business Overview
    Table 79. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 80. Luye Pharma Paclitaxel Injection Product
    Table 81. Luye Pharma Recent Development
    Table 82. Beijing Youcare Company Information
    Table 83. Beijing Youcare Description and Business Overview
    Table 84. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 85. Beijing Youcare Paclitaxel Injection Product
    Table 86. Beijing Youcare Recent Development
    Table 87. Beijing Union Company Information
    Table 88. Beijing Union Description and Business Overview
    Table 89. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 90. Beijing Union Paclitaxel Injection Product
    Table 91. Beijing Union Recent Development
    Table 92. Haiyao Company Information
    Table 93. Haiyao Description and Business Overview
    Table 94. Haiyao Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 95. Haiyao Paclitaxel Injection Product
    Table 96. Haiyao Recent Development
    Table 97. Chuntch Company Information
    Table 98. Chuntch Description and Business Overview
    Table 99. Chuntch Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 100. Chuntch Paclitaxel Injection Product
    Table 101. Chuntch Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Paclitaxel Injection Customers List
    Table 105. Paclitaxel Injection Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Paclitaxel Injection Product Picture
    Figure 2. Global Paclitaxel Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Paclitaxel Injection Market Size 2018-2029 (US$ Million)
    Figure 4. Global Paclitaxel Injection Sales 2018-2029 (K Units)
    Figure 5. India Paclitaxel Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Paclitaxel Injection Market Size 2018-2029 (US$ Million)
    Figure 7. India Paclitaxel Injection Sales 2018-2029 (K Units)
    Figure 8. India Paclitaxel Injection Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Paclitaxel Injection Market Share in Global, in Volume (K Units) 2018-2029
    Figure 10. Paclitaxel Injection Report Years Considered
    Figure 11. Product Picture of 5ml,30mg
    Figure 12. Product Picture of 10ml,60mg
    Figure 13. Product Picture of 16.7ml,100mg
    Figure 14. Product Picture of 25ml,150mg
    Figure 15. Product Picture of 50ml,300mg
    Figure 16. Global Paclitaxel Injection Market Share by Type in 2022 & 2029
    Figure 17. Global Paclitaxel Injection Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 18. Global Paclitaxel Injection Sales Market Share in Value by Type (2018-2029)
    Figure 19. Global Paclitaxel Injection Sales by Type (2018-2029) & (K Units)
    Figure 20. Global Paclitaxel Injection Sales Market Share in Volume by Type (2018-2029)
    Figure 21. Global Paclitaxel Injection Price by Type (2018-2029) & (USD/Unit)
    Figure 22. India Paclitaxel Injection Market Share by Type in 2022 & 2029
    Figure 23. India Paclitaxel Injection Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 24. India Paclitaxel Injection Sales Market Share in Value by Type (2018-2029)
    Figure 25. India Paclitaxel Injection Sales by Type (2018-2029) & (K Units)
    Figure 26. India Paclitaxel Injection Sales Market Share in Volume by Type (2018-2029)
    Figure 27. India Paclitaxel Injection Price by Type (2018-2029) & (USD/Unit)
    Figure 28. Product Picture of Ovarian Cancer
    Figure 29. Product Picture of Breast Cancer
    Figure 30. Product Picture of Cervical Cancer
    Figure 31. Product Picture of Pancreatic Cancer
    Figure 32. Product Picture of Other
    Figure 33. Global Paclitaxel Injection Market Share by Application in 2022 & 2029
    Figure 34. Global Paclitaxel Injection Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 35. Global Paclitaxel Injection Sales Market Share in Value by Application (2018-2029)
    Figure 36. Global Paclitaxel Injection Sales by Application (2018-2029) & (K Units)
    Figure 37. Global Paclitaxel Injection Sales Market Share in Volume by Application (2018-2029)
    Figure 38. Global Paclitaxel Injection Price by Application (2018-2029) & (USD/Unit)
    Figure 39. India Paclitaxel Injection Market Share by Application in 2022 & 2029
    Figure 40. India Paclitaxel Injection Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 41. India Paclitaxel Injection Sales Market Share in Value by Application (2018-2029)
    Figure 42. India Paclitaxel Injection Sales by Application (2018-2029) & (K Units)
    Figure 43. India Paclitaxel Injection Sales Market Share in Volume by Application (2018-2029)
    Figure 44. India Paclitaxel Injection Price by Application (2018-2029) & (USD/Unit)
    Figure 45. Americas Paclitaxel Injection Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 46. Americas Paclitaxel Injection Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 47. Americas Paclitaxel Injection Sales by Type (2018-2029) & (K Units)
    Figure 48. Americas Paclitaxel Injection Sales Market Share in Volume by Type (2018-2029)
    Figure 49. Americas Paclitaxel Injection Sales by Application (2018-2029) & (K Units)
    Figure 50. Americas Paclitaxel Injection Sales Market Share in Volume by Application (2018-2029)
    Figure 51. United States Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Canada Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 53. Mexico Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Brazil Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 55. EMEA Paclitaxel Injection Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 56. EMEA Paclitaxel Injection Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 57. EMEA Paclitaxel Injection Sales by Type (2018-2029) & (K Units)
    Figure 58. EMEA Paclitaxel Injection Sales Market Share in Volume by Type (2018-2029)
    Figure 59. EMEA Paclitaxel Injection Sales by Application (2018-2029) & (K Units)
    Figure 60. EMEA Paclitaxel Injection Sales Market Share in Volume by Application (2018-2029)
    Figure 61. Europe Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 62. Middle East Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 63. Africa Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 64. China Paclitaxel Injection Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 65. China Paclitaxel Injection Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 66. China Paclitaxel Injection Sales by Type (2018-2029) & (K Units)
    Figure 67. China Paclitaxel Injection Sales Market Share in Volume by Type (2018-2029)
    Figure 68. China Paclitaxel Injection Sales by Application (2018-2029) & (K Units)
    Figure 69. China Paclitaxel Injection Sales Market Share in Volume by Application (2018-2029)
    Figure 70. APAC Paclitaxel Injection Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 71. APAC Paclitaxel Injection Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 72. APAC Paclitaxel Injection Sales by Type (2018-2029) & (K Units)
    Figure 73. APAC Paclitaxel Injection Sales Market Share in Volume by Type (2018-2029)
    Figure 74. APAC Paclitaxel Injection Sales by Application (2018-2029) & (K Units)
    Figure 75. APAC Paclitaxel Injection Sales Market Share in Volume by Application (2018-2029)
    Figure 76. Japan Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. South Korea Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. China Taiwan Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 79. Southeast Asia Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 80. India Paclitaxel Injection Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 81. Paclitaxel Injection Value Chain
    Figure 82. Paclitaxel Injection Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS